Abstract
Adv Sci (Weinh). 2026 Nov 18:e78762. doi: 10.1002/advs.78762. Online ahead of print.
ABSTRACT
Despite success of therapies targeting the amyloid β-protein (Aβ), the molecular identity of the forms of Aβ which contribute to Alzheimer's disease (AD) remains poorly understood. SDS-stable Aβ dimers are present in higher-order aggregates and exert disease-relevant toxicity, but whether dimers form before or after large aggregates, or how dimers contribute to AD pathogenesis were previously unknown. Here, we report that covalently cross-linked Aβ1-42 dimers can form spontaneously upon prolonged incubation of Aβ fibrils and contain isopeptide bonds (Asp1-Glu22 and Asp1-Asp1), the same as those identified in dimers found in AD brain. Importantly, dimer-enriched Aβ aggregates (DEBA) are structurally distinct to dimer-poor aggregates (DPBA) and have enhanced resistance to proteolysis. Functionally, DEBA exhibit stronger binding to microglia, induce transcription of key pro-inflammatory cytokines, nucleate into plaque-like structures with microglia in vitro, and exacerbate amyloid deposition in AppNL-F/NL-F mice. DEBA do not appear to be overtly neurotoxic, whereas solubilized DEBA induce toxicities reminiscent of that caused by Aβ-containing AD brain extract. These findings demonstrate prolonged incubation of fibrillar Aβ aggregates results in spontaneous formation of cross-linked dimers, and this is associated with changes in aggregate morphology and emergence of multiple disease-relevant activities.
PMID:43052053 | DOI:10.1002/advs.78762
UK DRI Authors